Suppr超能文献

在体外循环心脏手术期间,胰蛋白酶原不会被激活。

Trypsinogen is not activated during cardiac surgery with extracorporeal circulation.

作者信息

Jönsson P, Borgström A, Steen S, Ohlsson K

机构信息

Department of Surgical Pathophysiology, Malmö General Hospital, Sweden.

出版信息

Scand J Clin Lab Invest. 1995 Aug;55(5):441-5. doi: 10.3109/00365519509104984.

Abstract

Amylase, immunoreactive cationic trypsin(ogen) and complexes of cationic trypsin and alpha 1-proteinase inhibitor were analysed in plasma samples from 41 patients following cardiac surgery with extracorporeal circulation. Postoperative hyperamylasaemia was seen in seven patients (17%). In 10 patients there were elevated levels (> 100 micrograms 1(-1)) of immunoreactive cationic trypsin(ogen) on the first postoperative day. After gelfiltration, samples from these 10 patients were analysed for trypsin-alpha 1-proteinase inhibitor complexes, with a solid-phase, double-antibody enzyme-linked immunoassay. The median preoperative level of trypsin-alpha 1-proteinase inhibitor complexes was 4.5 micrograms 1(-1) (range 3.3-11.9) and the median value on the first postoperative day was 5.5 micrograms 1(-1) (range 2.6-14). The ratio between complexes and immunoreactive trypsin(ogen) decreased (p < 0.05) showing that activation of trypsinogen did not occur. This fact argues against the development of protease-mediated subclinical pancreatitis during cardiac surgery with extracorporeal circulation.

摘要

对41例接受体外循环心脏手术患者的血浆样本进行了淀粉酶、免疫反应性阳离子胰蛋白酶(原)以及阳离子胰蛋白酶与α1-蛋白酶抑制剂复合物的分析。7例患者(17%)术后出现高淀粉酶血症。10例患者术后第1天免疫反应性阳离子胰蛋白酶(原)水平升高(>100μg 1(-1))。经凝胶过滤后,采用固相双抗体酶联免疫分析法对这10例患者的样本进行胰蛋白酶-α1-蛋白酶抑制剂复合物分析。术前胰蛋白酶-α1-蛋白酶抑制剂复合物的中位数水平为4.5μg 1(-1)(范围3.3 - 11.9),术后第1天的中位数为5.5μg 1(-1)(范围2.6 - 14)。复合物与免疫反应性胰蛋白酶(原)的比值降低(p<0.05),表明胰蛋白酶原未被激活。这一事实表明在体外循环心脏手术期间不会发生蛋白酶介导的亚临床胰腺炎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验